AMD
Advanced Micro Devices, Inc.
AMD's fundamentals are strong: revenue grew 42% and its operating margin rose 9 points to 18%. At 127x earnings, it's trading above its usual 113x. Analysts expect that strong growth to continue, though they disagree widely on how much.
CLSK
CleanSpark, Inc.
There isn't enough reported data to score CLSK yet.
AMD Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
AMD's revenue, profitability, cash flow and balance sheet are all currently strong.
CLSK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Unavailable | |
| Weak |
CLSK's revenue is currently healthy, but its profitability and balance sheet are weak. There isn't enough data to rate its cash flow.
AMD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 39x | $585 | — |
| Cheap | 40x | $182 | -69% |
| Fair | 112x | $514 | -12% |
| Current | 127x | $585 | — |
| Expensive | 206x | $947 | +62% |
Historical ranges are pointers, not guarantees.
AMD's PE is in its fair range at 127x. If earnings grow as analysts expect, today's price would be 39x next year's earnings, in its cheap range.
CLSK PE Valuation
CLSK has no meaningful PE right now: it lost money over the past year.
AMD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Low |
AMD has the edge over CLSK on the outlook, with more favorable earnings and revenue expectations.
CLSK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Stable | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect CLSK's losses to grow, with revenue holding steady. However, they disagree widely on these estimates.
AMD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $15.05 | +227% |
| Q3 2026 | $4.60 | +127% |
| Q2 2026 | $3.89 | +122% |
| Q1 2026 | $3.05 | +123% |
| Q4 2025 | $2.65 | +165% |
| Q3 2025 | $2.03 | +81% |
| Q2 2025 | $1.75 | +111% |
| Q1 2025 | $1.37 | +99% |
| Q4 2024 | $1.00 | +89% |
AMD has the edge over CLSK on earnings quality, reporting a profit while its opponent remains loss making.
CLSK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$3.80 | -614% |
| Q1 2026 | -$2.09 | -$1.02 |
| Q4 2025 | -$1.06 | -$1.06 |
| Q3 2025 | $1.12 | +$1.81 |
| Q2 2023 | -$1.77 | -$1.25 |
| Q1 2023 | -$2.36 | -$2.06 |
| Q4 2022 | -$2.13 | -$2.05 |
| Q3 2022 | -$1.35 | -$0.60 |
CLSK has swung to a loss: it lost $3.80 per share over the past year, after a profit the year before.
AMD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $13.4B | +45% |
| Q2 2026 | $11.5B | +50% |
| Q1 2026 | $10.3B | +38% |
| Q4 2025 | $10.3B | +34% |
| Q3 2025 | $9.2B | +36% |
| Q2 2025 | $7.7B | +32% |
| Q1 2025 | $7.4B | +36% |
| Q4 2024 | $7.7B | +24% |
CLSK has the stronger quarterly revenue trend. Revenue is up 45% for AMD versus up 70% for CLSK.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | +7.4 points |
| Q2 2026 | 17% | +19 points |
| Q1 2026 | 14% | +3.6 points |
| Q4 2025 | 17% | +5.7 points |
| Q3 2025 | 14% | +3.1 points |
| Q2 2025 | -1.7% | -6.4 points |
| Q1 2025 | 11% | +10 points |
| Q4 2024 | 11% | +5.8 points |
AMD's operating margin was 21% last quarter, up 7.4 points from the same quarter a year ago.
CLSK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2024 | $89.3M | +70% |
| Q2 2024 | $104.1M | +129% |
| Q1 2024 | $111.8M | +163% |
| Q4 2023 | $73.8M | +165% |
| Q3 2023 | $52.5M | +101% |
| Q2 2023 | $45.5M | +47% |
| Q1 2023 | $42.5M | +2.2% |
| Q4 2022 | $27.8M | -33% |
CLSK's revenue has grown year over year for seven quarters in a row: $89M last quarter, up 70% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2024 | -73% | +58 points |
| Q2 2024 | -239% | -205 points |
| Q1 2024 | 123% | +164 points |
| Q4 2023 | 39% | +143 points |
| Q3 2023 | -132% | +24 points |
| Q2 2023 | -34% | +14 points |
| Q1 2023 | -41% | -49 points |
| Q4 2022 | -104% | -115 points |
CLSK's operating margin was −73% last quarter, up 58 points from the same quarter a year ago.
AMD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $554M | -71% |
| Q2 2026 | $1.6B | -9.9% |
| Q1 2026 | $2.6B | +253% |
| Q4 2025 | $2.4B | +118% |
| Q3 2025 | $1.9B | +283% |
| Q2 2025 | $1.7B | +294% |
| Q1 2025 | $727M | +92% |
| Q4 2024 | $1.1B | +351% |
AMD has the stronger cash trend. Its trailing FCF is up 128% versus its history, compared with CLSK at down 283%.
CLSK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$118.4M | -$8.5M |
| Q1 2026 | -$173.4M | -$61.1M |
| Q4 2025 | -$198.1M | -$78.6M |
| Q2 2025 | -$109.9M | -$31.5M |
| Q1 2025 | -$112.3M | -$53.9M |
| Q4 2024 | -$119.5M | -$51.9M |
| Q3 2024 | -$95.5M | -$32.7M |
| Q2 2024 | -$78.3M | -$59.1M |
CLSK has burned cash in most quarters: −$600M over the past year, against −$406M the year before.
AMD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +2M shares |
| 1 year | +1.2% | +20M shares |
| 3 years | +2% | +32M shares |
| 5 years | +35% | +431M shares |
| Available history | +40% | +473M shares |
AMD has 1.7B diluted shares, up 1.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $221M |
| Q4 2025 | — |
| Q3 2025 | $89M |
| Q2 2025 | $478M |
| Q1 2025 | $749M |
| Q4 2024 | $256M |
AMD has spent almost nothing on buybacks in the past year.
CLSK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.1% | -11M shares |
| 1 year | -21% | -68.8M shares |
| 3 years | +287% | +190M shares |
| 5 years | +4901% | +252M shares |
CLSK has the edge over AMD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $460M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $145M |
CLSK spent $460M buying back its own shares over the past year.
AMD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2020 | -1.0x | Net Cash |
| Q1 2020 | -0.8x | Net Cash |
| Q4 2019 | -1.2x | Net Cash |
AMD has more cash than debt.
CLSK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 150.4x | High |
| Q4 2025 | 7.4x | High |
| Q3 2025 | 0.9x | Very low |
| Q2 2025 | 1.1x | Healthy |
| Q4 2024 | 1.6x | Healthy |
| Q3 2024 | -20.5x | Net Cash |
| Q2 2024 | -14.8x | Net Cash |
| Q1 2024 | -1.4x | Net Cash |
CLSK's net debt is more than 20 years of its operating earnings (EBITDA), up from 1.6 years a year ago.
AMD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.3 | Neutral |
| Stochastic | 41.4 | Neutral |
AMD's weekly RSI is 59 (neutral) and its Stochastic is 41 (neutral).
CLSK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 8.2 | Oversold |
CLSK's weekly RSI is 34 (neutral) and its Stochastic is 8 (oversold).
AMD PE vs Technology Sector
| Metric | AMD | Sector median | Relative |
|---|---|---|---|
| PE | 127x | 28x | 357% above |
| PE % | 61 | 35 | 26 pts above |
AMD is trading at 127x earnings, a 357% premium to the Technology sector's median of 28x.
CLSK PE vs Technology Sector
| Metric | CLSK | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CLSK has no meaningful PE right now: it lost money over the past year.
AMD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $557.2 | 5.1% above |
| 20 week MA | $525.9 | 11% above |
| 50 week MA | $389.7 | 50% above |
| 100 week MA | $266.9 | 119% above |
| 200 week MA | $199.6 | 193% above |
AMD has the edge over CLSK on trend strength, trading above more of its moving averages.
CLSK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.27 | 26% below |
| 20 week MA | $11.5 | 40% below |
| 50 week MA | $12.0 | 43% below |
| 100 week MA | $11.5 | 41% below |
| 200 week MA | $10.5 | 35% below |
CLSK is in a downtrend: it's below all five of its weekly moving averages, and 35% below its 200-week average.
AMD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.2 | $91.8 | +99% |
| 2021 | $91.8 | $146.1 | +59% |
| 2022 | $146.1 | $64.5 | -56% |
| 2023 | $64.5 | $147.4 | +128% |
| 2024 | $147.4 | $125.2 | -15% |
| 2025 | $125.2 | $215.0 | +72% |
| 2026 YTD | $215.0 | $585.3 | +172% |
AMD has the edge over CLSK on returns for 2026, with the stronger performance.
CLSK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.2 | $24.9 | +54% |
| 2021 | $24.9 | $11.9 | -52% |
| 2022 | $11.9 | $1.97 | -83% |
| 2023 | $1.97 | $11.0 | +460% |
| 2024 | $11.0 | $9.78 | -11% |
| 2025 | $9.78 | $10.9 | +12% |
| 2026 YTD | $10.9 | $6.84 | -37% |
CLSK's yearly returns have swung widely, from +460% in 2023 to −83% in 2022. It's down 37% so far in 2026.